1 documents found
Information × Registration Number 0212U001609, 0107U002244 , R & D reports Title The investigations of new approaches to differential diagnosis and oncolytic therapy of human tumors popup.stage_title Head Sidorenko Svitlana Pavlivna, Registration Date 14-02-2012 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 It was shown that CD150 is expressed on mRNA and protein levels in glioma cell lines and is a marker of tumor cells in central nervous system. The novel CD150 isoform containing an 83 bp insert encoded by additional exon was identified. This novel CD150 isoform is expressed in malignant cells of central nervous system. It was found that CD150 expressing Hodgkin's lymphoma cell lines are highly sensitive to wild type measles virus and canine distemper virus infections that is prerequisite for they as a agent in oncolytic therapy of CD150 - positive tumors. Product Description popup.authors Бердова Г.Г. Ковалевська Л.М. Міхалап С.В. Романець О.Л. Сидоренко С.П. Шабельник М.Ю. Шлапацька Л.М. Юрченко М.Ю. popup.nrat_date 2020-04-02 Close
R & D report
Head: Sidorenko Svitlana Pavlivna. The investigations of new approaches to differential diagnosis and oncolytic therapy of human tumors. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0212U001609
1 documents found

Updated: 2026-03-25